Pentobarbital Sodium Is Used to End Suffering — and Also to Execute People. The Debate Is Getting Louder.

In a prison in Arizona, a tiny vial is kept in a refrigerator. Or there was—the precise state of what’s inside is still up for debate. The contents may have expired, according to a retired judge looking into the state’s execution procedures. They would not expire, according to prison officials. This could not be independently verified by anyone outside the prison. Pentobarbital sodium is the drug in question, and the fact that its storage conditions in a correctional facility are now the focus of legal investigation indicates how far this specific compound has deviated from its intended use.
Before benzodiazepines largely took their place in clinical settings during the 1970s and 1980s, pentobarbital sodium, a member of the barbiturate class of central nervous system depressants, was frequently prescribed for anxiety and insomnia. The medication produces a cascade of CNS depression that, depending on the dosage, can range from mild sedation to an induced coma by binding to GABA-A receptors in the brain and extending the time that chloride channels remain open. Pre-surgical sedation, short-term treatment of insomnia, and emergency management of status epilepticus—a type of prolonged seizure that, if left untreated, can result in irreversible brain damage—are the limited uses for which the FDA has approved it. When seizures are unresponsive to all other treatments, it can be used to put a patient in a medically induced coma at high doses administered by slow intravenous infusion in an intensive care unit.

It becomes complicated when it comes to its off-label uses. Pentobarbital sodium is a common euthanasia solution in veterinary medicine. A veterinary pharmaceutical company called Parnell introduced a pentobarbital sodium and phenytoin sodium solution specifically for dogs in March 2026. It comes in 100 mL multi-dose vials and is colored with a unique bluish-red dye to set it apart from therapeutic drugs. According to the company, the product is intended for “compassionate, calm, and dignified experiences.” Knowing that the same substance is being discussed concurrently in state and federal courts as part of the U.S. lethal injection protocol gives that language a certain weight.

Pentobarbital executions were resumed by the federal government in July 2019 following a 16-year hiatus, which was ordered by then-Attorney General William Barr. The drug was already being used for the death penalty in a number of states, including Texas, Missouri, and Georgia. There are several facets to the controversy surrounding this use. The supply chain for state execution programs has become extremely challenging to manage because pharmaceutical manufacturers, including some European companies, have refused to permit their pentobarbital to be sold to prisons for this purpose. In 2025, the governor of Indiana admitted that pentobarbital was “a very difficult drug to get.” One obvious sign of that larger supply issue is the Arizona stockpile situation, which includes hidden jars in a prison refrigerator, concerns about expiration, and skepticism from a retired judge.
It’s unclear if a potentially expired medication is less effective for the intended use, or if it’s even appropriate to ask that question. Opponents of lethal injection contend that the practice itself, rather than the drug’s freshness, is the real issue, and that the rush to acquire pentobarbital is a reflection of an institutional reluctance to address this claim head-on. Proponents of the protocol cite the drug’s quick onset—intravenous pentobarbital enters the brain more quickly than many rival medications—as proof that it has a humane effect. Both viewpoints coexist with the clinical fact that pentobarbital has a limited therapeutic index and a significant risk of side effects if used improperly.
An already complex picture was further complicated in 2024 by a federal trafficking case. A Mexican national was charged by a grand jury for allegedly bringing pentobarbital into the US illegally; some of the buyers were later discovered dead. The medication had been obtained outside of any legal medical supervision framework for the purpose of assisted suicide. It’s a somber example of the demand for controlled access to a drug that can result in a peaceful death. Legal assisted dying programs in countries like Switzerland and Canada have tried to channel this demand through regulated channels, using pentobarbital under medical supervision for terminally ill patients who have run out of other options.
As all of this has developed over the years, it seems as though pentobarbital has turned into a sort of Rorschach test for how society responds to the most sensitive issues regarding death and suffering. It is used by veterinarians to put an end to animal suffering. It is used by researchers to put lab mice to sleep. It is used by neurologists to reduce catastrophic seizures. It is used by prison officials to execute court-mandated sentences. When their illness becomes intolerable, some patients look for it as a last resort. The drug itself remains the same in all of these situations. Depending on who is holding the syringe and why, the weight that is applied to it varies significantly. For a crystalline white powder to bear that much moral burden is astounding.